CDW vs LAB · P/E 22, rev $21.00B vs rev $174.4M
CDW Corp (CDW) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
CDW Corp (CDW) is a information technology services company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CDW currently screens at market cap $23.36B and trailing P/E 22.0. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CDW and LAB stock pages for the full models.
Not investment advice.